|
CCDC117 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.810400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.691000E-01 |
| Normal-vs-Stage2 |
9.847800E-01 |
| Normal-vs-Stage3 |
5.761400E-01 |
| Normal-vs-Stage4 |
6.029800E-01 |
| Stage1-vs-Stage2 |
5.611400E-01 |
| Stage1-vs-Stage3 |
1.877410E-01 |
| Stage1-vs-Stage4 |
8.465200E-01 |
| Stage2-vs-Stage3 |
7.006000E-01 |
| Stage2-vs-Stage4 |
6.826200E-01 |
| Stage3-vs-Stage4 |
3.367200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.920200E-01 |
| Normal-vs-AfricanAmerican |
3.566000E-02 |
| Normal-vs-Asian |
3.591600E-01 |
| Caucasian-vs-AfricanAmerican |
1.879560E-03 |
| Caucasian-vs-Asian |
6.485600E-01 |
| AfricanAmerican-vs-Asian |
5.341600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.668200E-01 |
| Normal-vs-Female |
6.044200E-01 |
| Male-vs-Female |
7.860200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.743170E-01 |
| Normal-vs-Age(41-60Yrs) |
3.332800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.449800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.706600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.552200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.384370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.576000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.193200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.838200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.897400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.346200E-01 |
| Normal-vs-Grade 2 |
1.453200E-01 |
| Normal-vs-Grade 3 |
5.016200E-01 |
| Normal-vs-Grade 4 |
7.182200E-01 |
| Grade 1-vs-Grade 2 |
8.383800E-01 |
| Grade 1-vs-Grade 3 |
4.866400E-01 |
| Grade 1-vs-Grade 4 |
5.611600E-01 |
| Grade 2-vs-Grade 3 |
1.913590E-02 |
| Grade 2-vs-Grade 4 |
9.546100E-02 |
| Grade 3-vs-Grade 4 |
8.528600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.486000E-02 |
| Normal-vs-ccB subtype |
9.278000E-01 |
| ccA subtype-vs-ccB subtype |
1.198980E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.447000E-01 |
| Normal-vs-N1 |
8.393800E-01 |
| N0-vs-N1 |
9.464400E-01 |
|
|
